Check out your Company Bowl for anonymous work chats.
Women of childbearing age (WoCBA) living with chronic diseases such as rheumatoid arthritis, axial spondyloarthritis, psoriasis, epilepsy, and multiple sclerosis continue to face significant healthcare challenges, despite rapid advancements in the medical field. More than ever, identifying how to enhance the healthcare experience of these women is a priority. Read more...
In a world where scientific innovation is advancing at an unprecedented pace, it's easy to get caught up in the excitement of cutting-edge technology. However, at UCB, we think technology is only part of the innovation puzzle. UCB's ethos is deeply rooted in the belief that innovation should revolve around the patients we serve, and we have a culture where the patient is not just the end-user, but the beginning and the centerpiece of every breakthrough. Patient-centricity is at the heart of everything we do. Read more...
UCB was just named to the "Innovators 2015: Companies" list by PM360 for our focus on creating value for our patients. Thank you to all our colleagues who live this mantra every day. http://glassdoor.com/slink.htm?key=vImPO
Precision medicine is a hot topic in the healthcare world. But what exactly is precision medicine, and how can it help us accomplish our goal of delivering the right treatment to the right patient at the right time? http://glassdoor.com/slink.htm?key=vIG2v
UCB has a strong presence at medical congresses because sharing scientific knowledge drives medicine forward – and helps us deliver solutions for patients http://glassdoor.com/slink.htm?key=vI1Vy
Europe has some of the world's most promising rising starts in neurology. Click through to read how UCB is playing its part in connecting the best and the brightest: http://glassdoor.com/slink.htm?key=vIK3H
Strong growth in the first half of 2015 from our three core medicines ensures UCB continues on its growth path Click through to learn more: http://glassdoor.com/slink.htm?key=vIKSq
What do patients want? UCB convened an online meeting of 200 patients to ask them what they want from the healthcare system. Click through to learn more: http://glassdoor.com/slink.htm?key=vIK1R
UCB's ability to develop and manufacture innovative medicines that improve patients' lives depends on the talent of our researchers. We were delighted to see Stefanos Grammatikos, Head of Biotech Services, presented with the ESACT Medal in recognition of his contribution to the field. Click through to learn more: http://glassdoor.com/slink.htm?key=vIKWq
Today is World Brain Day and the focus is on the most common chronic serious disease of the brain – epilepsy. With treatment, 70% of people with epilepsy could be seizure free. Click through to learn more: http://glassdoor.com/slink.htm?key=vIKwW
